Video

VIDEO: Unclear if altering lifestyle affects breast cancer


 

AT THE 2014 ASCO BREAST CANCER SYMPOSIUM

References

SAN FRANCISCO – Physicians have multiple good reasons to suggest lifestyle changes to many patients with breast cancer, but affecting the cancer itself may not be one of them, Dr. Pamela J. Goodwin said at a breast cancer symposium sponsored by the American Society of Clinical Oncology.

In this video interview, Dr. Goodwin summarizes the ongoing research on how changes in lifestyle such as weight loss, diet, physical activity, and drinking may or may not alter outcomes in patients with breast cancer.

The good news: A drink or two a day probably doesn’t hurt, said Dr. Goodwin, professor of medicine at the University of Toronto’s Mount Sinai Hospital.

She reported having no financial disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

sboschert@frontlinemedcom.com

On Twitter @sherryboschert

Recommended Reading

For advanced HER2-negative breast cancer, no best treatment
MDedge Hematology and Oncology
VIDEO: NCI’s Dr. Steven Rosenberg talks TILs in breast cancer and much more
MDedge Hematology and Oncology
Researchers deem tumor-infiltrating lymphocytes valid prognostic biomarker in TNBC
MDedge Hematology and Oncology
Locoregional recurrence of breast cancer less likely after neoadjuvant complete response
MDedge Hematology and Oncology
PIK3CA mutations linked to lower pCR rates in women with HER2-positive breast cancer
MDedge Hematology and Oncology
VIDEO: Complications increase with bilateral mastectomy and reconstruction
MDedge Hematology and Oncology
VIDEO: Breast cancer symposium take-home messages, Day 1
MDedge Hematology and Oncology
VIDEO: Dr. Hope S. Rugo on breast cancer symposium hot topics, Day 2
MDedge Hematology and Oncology
VIDEO: ASCO Breast Cancer Symposium final wrap-up with Dr. Hope S. Rugo
MDedge Hematology and Oncology
VIDEO: Low recurrence with high HER2 expression and a GP2 peptide vaccine
MDedge Hematology and Oncology